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Abstract. Breast cancer is a major health problem for women. This cancer is most often 
diagnosed and the leading cause of cancer deaths in women worldwide. Breast cancer in 
young women is associated with late diagnosis, aggressive biological characteristics, and 
poor prognosis. The objective of the study is to determine the prevalence and characteristics 
of young age breast cancer in Haji Adam Malik General Hospital Medan in 2013-2017. The 
study design was observational descriptive design with a cross-sectional approach. The study 
samples were medical records of young women diagnosed with breast cancer who were 
treated at Haji Adam Malik General Hospital Medan. The prevalence of breast cancer in 
young age women in Haji Adam Malik General Hospital Medan in 2013-2017 was 234 
patients (15.2%). In this study, the samples that fulfilled the inclusion criteria were 153, with 
the majority characteristics of patients were 35-39 years old, stage III, histopathological type 
of invasive carcinoma of no special type, grade II, and clinical subtype of triple-negative. 
The prevalence of young age breast cancer is lower than old age breast cancer. Young women 
tend to be diagnosed with breast cancer in advanced stage and intermediate grade with 
aggressive biological characteristics. 
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1. Introduction 
 Cancer is a disease that can cause cells in the body to change and spread uncontrollably. 
When cancer cells are first discovered in the breast, it is called breast cancer. Most breast cancer 
cells will form a lump or mass called tumor. These malignant cells in breast cancer usually grow 
in breast tissue that appears in the lobules and ducts in the breast [1]. Risk factors for breast cancer 
can be distinguished into reproductive and non-reproductive factors. Reproductive factors are 
early menarche (<12 years), late menopause (>55 years), history of first pregnancy over the age 
of 30 years, never giving birth (nulliparity) and breastfeeding, and oral contraceptive use. 
Whereas non-reproductive factors are obesity, alcohol consumption, smoking, radiation history 
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during childhood, family history and genetic predisposition (BRCA1 or BRCA2 gene 
mutations)[2]-[3]. 
 Breast cancer is the second most common cancer in the world and, so far, the most common 
cancer in women with an estimated incidence of 2.1 million diagnosed in 2018 (24.2% of all 
cancers). This disease is the most commonly diagnosed cancer in most countries (154 of 185 
countries) and is also a leading cause of cancer death in more than 100 countries. Breast cancer 
is the fifth in the overall cause of cancer deaths (626,679 deaths) and while it is the highest cause 
of death from cancer in women. Indonesia is in the 8th rank for the highest number of breast cancer 
new cases and 5th rank for the highest number of cases of breast cancer deaths in the world in 
2018[4]. 
 Breast cancer can be diagnosed through triple assessment, namely clinical (history taking, 
physical examination), radiological and pathology examination. The assessment is a guide in 
diagnosis, determining the stage of breast cancer, determining the histopathological type, grading, 
and clinical subtypes of tumor that can be used in deciding therapy and the prognosis of breast 
cancer patients[5]. 
 Breast cancer in young women is very rare. The cases with criteria for ages 20-39 years 
worldwide are approximately 243,096 new cases (11%) and 44,698 deaths from cancer[6]. They 
have major risk factors, such as heredity, mostly diagnosed with genetic mutations. Breast cancer 
in young women has unique characteristics, which are not found in older women, like aggressive 
biological characteristics (histopathological type and clinical subtype) and poor differentiation. 
In young women, breast cancer tends to be diagnosed in its advanced stage and higher grade breast 
tumors compared to older women[7]. This can lead to a worse prognosis than the prognosis of 
older premenopausal and postmenopausal women with breast cancer. Problems commonly found 
in young women are late diagnosis, lack of screening, and higher tumor growth rate[8]. 
 Based on the description above, breast cancer is commonly found in the world, one of the 
countries is Indonesia, with high incidence and mortality. Breast cancer can be suffered by all 
ages, not only for older women but also for young women (<40 years) and has a poor prognosis. 
Therefore, this study was conducted to determine the prevalence and characteristics of breast 
cancer, such as stage, histopathological type, grade, and clinical subtype in young women (<40 
years) at Haji Adam Malik General Hospital Medan in 2013-2017.  




 The research design used in this study was observational descriptive with a cross-sectional 
design approach. The samples in this study were medical records of breast cancer patients younger 
than 40 years who were treated at Haji Adam Malik General Hospital Medan. The sampling 
technique in this study was consecutive sampling. In this study, the inclusion criteria are: 1) the 
first age of diagnosis of breast cancer are younger than 40 years; 2) the patient has undergone 
physical and pathology examination (histopathology and immunohistochemistry) and is fully 
recorded in the medical record; while the exclusion criteria are: 1) patients with cancer in other 
organs that are not breast cancer metastatis; 2) incomplete medical and diagnosis records. After 
collecting the samples, 153 medical records fulfilled the inclusion criteria of this study. 
 The variables studied included: 1) the age of the first diagnosis, with classifications of less 
than 25 years, 25-29 years, 30-34 years, and 35-39 years; 2) stage, with classifications of stage 0, 
stage I (A, B), stage II (A, B), stage III (A, B, C), and stage IV; 3) histopathological type, with 
classifications of invasive (NST, lobular, tubular) and in-situ breast cancer; 4) grade, with grade 
I, grade II, and grade III classifications; 5) clinical subtypes, with luminal A, luminal B, HER2-
enriched, and triple-negative classifications. 
 Before the study was conducted, Ethical Clearance had been conducted and approved by the 
Ethics Committee of Faculty of Medicine USU. The data sources are secondary data, which is 
medical and diagnosis record data of the patients in 2013-2017 obtained at Medical Records 
Department and Department of Surgical Oncology at Haji Adam Malik General Hospital Medan. 
The processed data is analyzed using the Statistical Product and Service Solutions (SPSS) 
program. 
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RESULTS AND DISCUSSION 
 Among 1,543 breast cancer patients at Haji Adam Malik General Hospital Medan, 234 
(15.2%) are younger than 40 years old. The population of young breast cancer patients in 2013, 
2014, 2015, 2016, and 2017 were 33, 37, 58, 63, and 43, respectively. The amount of data that 
fulfilled the inclusion criteria, or samples in this study, were 153 data (Table 1).  
Table 1 The prevalence of breast cancer in 2013-2017 
Year 
< 40 years ≥ 40 years Breast cancer 
patients Frequency Percentage (%)  Frequency Percentage (%)  
2013 33 12,7 226 87,3 259 
2014 37 15,2 244 84,8 281 
2015 58 18,7 252 81,3 310 
2016 63 18,2 284 81,8 347 
2017 43 12,4 303 87,6 346 
Total 234 15,2 1.309 84,8 1.543 
 
 Based on the patients’ age at diagnosis, the median age was 35 (minimum and maximum 
age of 21 and 39). The majority age interval was 35-39 years (63.4%), followed by 30-34 years 
(26.1%), 25-29 years (9.2%), and <25 years (1.3%). Clinically, 1.3% and 14.4% of patients 
diagnosed with stage I and stage II (early-stage breast cancer), 49% with stage III (locally 
advanced), and 35.8% with stage IV (advanced stage). From breast tumors characteristics, the 
most common histopathological type was invasive carcinoma of no special type / ductal 
carcinoma (88.9%). The others were invasive lobular carcinoma (7.8%), invasive tubular 
carcinoma (2.6%) and inflammatory carcinoma (0.7%). No in-situ breast cancer data was found 
in this study. The patients with grade I, II, III, were 15.7%, 64%, and 20.3%, respectively. Triple-
negative was the most clinical subtype found in young age breast cancer (31.4%), followed by 
luminal A (28.1%), luminal B (24.2%), and HER2-enriched (16.3%) (Table 2). 
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Table 2 The characteristics of young breast cancer (153 patients) 
Characteristics  Frequency Percentage (%) 
Age at diagnosis (interval) 
< 25 2 1,3 
25-29 14 9,2 
30-34 40 26,1 
35-39 97 63,4 
Staging 
Stage I 2 1,3 
Stage II 22 14,4 
Stage III 75 49,0 
Stage IV 54 35,3 
Histopathological type 
Invasive carcinoma of no special type 136 88,9 
Invasive lobular carcinoma 12 7,8 
Invasive tubular carcinoma 4 2,6 
Inflammatory carcinoma 1 0,7 
Grading 
Grade I 24 15,7 
Grade II 98 64,0 
Grade III 31 20,3 
Clinical subtype   
Luminal A 43 28,1 
Luminal B 37 24,2 
HER2-enriched 25 16,3 
Triple-negative 48 31,4 
 
 Breast cancer in young women has a definition that varies between the ages of 35 or 40 
years. To date, there is no consensus for defining breast cancer in 'young' and 'very young' women, 
with various studies using ages 30, 35, 40, and 45 years as the cutoff age in various research[7]. 
 The prevalence of young age breast cancer in Haji Adam Malik General Hospital Medan in 
2013-2017 is 234 patients, or 15.2% of all breast cancer cases, which the percentage is lower than 
old age breast cancer. Similar study has been carried out at Sanglah Hospital using medical record 
data in 2002-2012 and 2014-2016, with the proportions of breast cancer aged <40 years are 22.7% 
and 14% [9][10]. International Agency for Research on Cancer shows young age breast cancer 
cases in Asia are higher than those in America and Europe, according to breast cancer cases at 
<40 years of age which is Asia has the highest prevalence in the world[4]. Research conducted in 
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 The majority of breast cancers in young women in Haji Adam Malik General Hospital 
Medan occur in the age range of 35-39 years. This result is suitable with the study in Sanglah 
General Hospital with the majority of cases occured in the age range of 35-39 years. The 
increasing number of cases occurs along with increasing age. Other studies also state that breast 
cancer cases increase with increasing age in the age limit of <40 years[9][11][14]. 
 Delay in diagnosis often occurs in young patients with breast cancer, which results in patients 
being first diagnosed with advanced and intermediate-high-grade breast cancer[9][13][15][16], 
caused by low awareness of patients for early detection (screening) and lack of patient knowledge 
about breast cancer. The delay can occur not only because patients just visit health facilities 
because of complaints about their breasts, but also because doctors who are less alert in 
diagnosing breast cancer and referring patients for immediate therapy. It is also difficult for 
doctors to diagnose young age breast cancer due to increased breast density of young women. In 
addition, more aggressive tumor biology and more rapid tumor progression in younger patients 
are indicative of more advanced disease at diagnosis[7][8][17][18]. 
 Young women with breast cancer tend to have tumor with aggressive biological 
characteristics. Invasive carcinoma is mostly found in the tumor of the patients, with the majority 
type is invasive carcinoma of no special type / ductal carcinoma (NST). Most of the studies that 
have been carried out show that invasive carcinoma of a special type (NST) is the most 
histopathological type found in women, both young and old, with breast cancer[13][16][17].  
 Based on gene expression profiling analysis (IHC), most tumors of young age breast cancer 
have no hormone-receptor (ER, PR) and no HER2, or in the other words, the clinical subtype is 
triple-negative. Some studies also found triple-negative was the most clinical subtypes in women 
with breast cancer at the age of <40 years [19][20][21]. Immunohistochemical examination is a 
standard in determining breast cancer subtypes. Determination of subtypes in breast cancer will 
play a role in helping determine the type and prediction of systemic therapy response and 
prognosis of the patients[5]. The triple-negative subtype in young women has worse prognosis 
than that in older women, but the risk of recurrence and death do not increase in patients who 
have received therapy[22]. 
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CONCLUSIONS AND FUTURE RESEARCH 
 The prevalence of breast cancer in young women (<40 years) is lower than the prevalence 
in older women who were admitted to Haji Adam Malik General Hospital Medan in 2013-2017. 
The majority characteristics of breast cancer in young women in this study were aged 35-39 years, 
who were diagnosed with aggressive and advanced biological characteristics, namely locally-
advanced stage, histopathological type of invasive carcinoma of special type / NST, intermediate 
grade, and triple-negative clinical subtype. 
 Next researchers can look for a relationship between the characteristics found in breast 
cancer patients with young age (<40 years), and look for the relationship of hereditary (history of 
breast cancer in the family), reproductive (early menarche, history of contraceptive use) and non-
reproductive (lifestyle) risk factors with the prevalence of breast cancer in young women. 
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